HMGB1 promotes neutrophil PD-L1 expression through TLR2 and mediates T cell apoptosis leading to immunosuppression in sepsis
International Immunopharmacology · 2024-05 · 133 · 112130
DOI: 10.1016/j.intimp.2024.112130 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Immunopharmacology, 2024-05. Verfasst von Jinlian Liu und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pathophysiology, Guangdong Provincial Key Laboratory of Cardiac Function and Microcirculation, Guangdong Provincial Key Laboratory of P…. Hauptthemen laut MEDLINE: Apoptosis, B7-H1 Antigen, HMGB1 Protein, Sepsis. Die Arbeit wurde bisher 37-mal zitiert (Crossref) und nennt 37 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: National Natural Science Foundation of China.
Themen: Sepsis
Abstract (Originalsprache)
Neutrophils and T lymphocytes are closely related to occurrence of immunosuppression in sepsis. Studies have shown that neutrophil apoptosis decreases and T lymphocyte apoptosis increases in sepsis immunosuppression, but the specific mechanism involved remains unclear. In the present study, we found Toll-like Receptor 2 (TLR2) and programmed death-ligand 1 (PD-L1) were significantly activated in bone marrow neutrophils of wild-type mice after LPS treatment and that they were attenuated by treatment with C29, an inhibitor of TLR2. PD-L1 activation inhibits neutrophil apoptosis, whereas programmed death protein 1 (PD-1)activation promotes apoptosis of T lymphocytes, which leads to immunosuppression. Mechanistically, when sepsis occurs, pro-inflammatory factors and High mobility group box-1 protein (HMGB1) passively released from dead cells cause the up-regulation of PD-L1 through TLR2 on neutrophils. The binding of PD-L1 and PD-1 on T lymphocytes leads to increased apoptosis of T lymphocytes and immune dysfunction, eventually resulting in the occurrence of sepsis immunosuppression. In vivo experiments showed that the HMGB1 inhibitor glycyrrhizic acid (GA) and the TLR2 inhibitor C29 could inhibit the HMGB1/TLR2/PD-L1 pathway, and improving sepsis-induced lung injury. In summary, this study shows that HMGB1 regulates PD-L1 and PD-1 signaling pathways through TLR2, which leads to immunosuppression.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Pathophysiology, Guangdong Provincial Key Laboratory of Cardiac Function and Microcirculation, Guangdong Provincial Key Laboratory of Proteomics, State Key Laboratory of Organ Failure Research, National Ex…
- Department of Medical Critical Care Medicine, General Hospital of Southern Theatre Command of PLA, 2. Guangdong Branch Center, National Clinical Research Center for Geriatric Diseases (Chinese PLA General Hospital), Gua…
Förderung
- National Natural Science Foundation of China
Zitieren
APA
Liu, J., Song, K., Lin, B., Chen, Z., Zuo, Z., Fang, Y., He, Q., Yao, X., Liu, Z., Huang, Q., & Guo, X. (2024). HMGB1 promotes neutrophil PD-L1 expression through TLR2 and mediates T cell apoptosis leading to immunosuppression in sepsis. International Immunopharmacology, 133, 112130. https://doi.org/10.1016/j.intimp.2024.112130
Vancouver
Liu J, Song K, Lin B, Chen Z, Zuo Z, Fang Y, et al. HMGB1 promotes neutrophil PD-L1 expression through TLR2 and mediates T cell apoptosis leading to immunosuppression in sepsis. International Immunopharmacology. 2024;133:112130. doi:10.1016/j.intimp.2024.112130
BibTeX
@article{Liu2024,
author = {Liu, Jinlian and Song, Ke and Lin, Bingqi and Chen, Zhenfeng and Zuo, Zirui and Fang, Yixing and He, Qi and Yao, Xiaodan and Liu, Zhifeng and Huang, Qiaobing and Guo, Xiaohua},
title = {HMGB1 promotes neutrophil PD-L1 expression through TLR2 and mediates T cell apoptosis leading to immunosuppression in sepsis},
journal = {International Immunopharmacology},
year = {2024},
volume = {133},
pages = {112130},
doi = {10.1016/j.intimp.2024.112130}
}
EUVIMED